Gut bacteria treatment tested for bowel disease
Disease control
Terminated
This study tested VE202, a treatment made from specific live bacteria, in people with mild-to-moderate ulcerative colitis (UC). The goal was to see if changing the gut's bacterial community could safely reduce bowel inflammation and improve symptoms. The trial was terminated earl…
Phase: PHASE2 • Sponsor: Vedanta Biosciences, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC